Objectives To evaluate the usefulness of I-123-labelled anti-vascular cell
adhesion molecule-12 (VCAM-1) monoclonal antibody (MAb) scintigraphy in the
assessment of colonic inflammatory damage.
Design Colitis was induced by intracolonic administration of 30 mg trinitro
benzenesulphonic acid in 0.5 mi of 50% (v/v) ethanol. Rats injected with ve
hicle served as controls. Animals were studied at day 7 after induction of
colitis.
Methods Scintigraphy was performed in control and trinitrobenzenesulphonic
acid-induced colitic rats 2, 4 and 24 h after intravenous administration of
I-123-anti-VCAM-1 MAb, Scintigraphic uptake was quantified in selected are
as on scintigraphs. Animals were killed, tissue I-123 radioactivity accumul
ation was measured, and accumulation of anti-VCAM-1 MAb in each organ was c
alculated. Tc-99m-hexamethyl propylene amine oxime-labelled leucocyte scint
igraphy was performed in additional groups of animals for comparison.
Results Colonic tracer uptake was visible in scans of colitic, but not cont
rol animals. Quantification of scintigraphic uptake in the colon was signif
icantly higher in colitic rats than in control animals (P < 0.0001). The sp
ecificity of the increase was demonstrated by lack of I-123-labelled non-bi
nding MAb uptake in the colon, and by displacement of I-123-anti-VCAM-1 MAb
colonic uptake by pre-treatment with unlabelled MAb. Accumulation of anti-
VCAM-1 MAb in the colon of colitic rats was eightfold higher than in contro
l animals. Strong correlations were found between quantification of scintig
raphic uptake, anti-VCAM-1 MAb accumulation, histological damage and myelop
eroxidase activity in the colon.
Conclusion I-123-labelled anti-VCAM-1 MAb scintigraphy allows an accurate e
valuation of colonic inflammatory damage in trinitrobenzenesulphonic acid-i
nduced colitis, suggesting a potential role for this imaging technique in t
he assessment of human IBD. Eur J Gastroenterol Hepatol 13:31-38 (C) 2001 L
ippincott Williams & Wilkins.